recon_clarity
Reconstitution clarity, visible particulates, and how long to wait before judging.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
8
n=8
Annotations
0
n=0
Median purity submitted
98.48%
n=8
Suppliers covered
6
n=8
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-042013 | GHRP-6 | AMB | AMB-2603-S5667 | Kestrel | 2026-Q3 | 99.93 | 5.75 | — | Buyer-sourced | 0 | PASS |
| AX-2026-043008 | L-Glutathione (reduced) | MKM | MKM-2602-X4844 | PeptideMeter | 2026-Q2 | 98.39 | 9.13 | 94.9 | Buyer-sourced | 1 | FAIL |
| AX-2026-043004 | Semaglutide | MKM | MKM-2601-Y4342 | Medutest | 2026-Q2 | 98.05 | 3.62 | 101.6 | Buyer-sourced | 0 | PASS |
| AX-2025-019995 | IGF-1 LR3 | SWB | SWB-2510-U7690 | Medutest | 2025-Q4 | 98.57 | 5.61 | 88.0 | Buyer-sourced | 2 | MARGINAL |
| AX-2025-019397 | CJC-1295 (no DAC) | HYB | HYB-2504-N7248 | VendorInvestigate | 2025-Q3 | 98.89 | 4.10 | — | Buyer-sourced | 0 | PASS |
| AX-2024-005277 | Tirzepatide | BCH | BCH-2407-F4650 | Janoshik | 2024-Q4 | 97.17 | 5.40 | 91.4 | Buyer-sourced | 2 | MARGINAL |
| AX-2024-005127 | Tirzepatide | SGN | SGN-2411-N9012 | Kestrel | 2024-Q4 | 99.14 | 3.39 | — | Buyer-sourced | 0 | PASS |
| AX-2024-005288 | Cagrilintide | BCH | BCH-2402-C5045 | PeptideMeter | 2024-Q2 | 97.76 | 3.83 | 93.3 | Buyer-sourced | 0 | PASS |